Hyercalcemia induced by interferon therapy in chronic hepatitis C

Interferon is being increasingly used in the treatment of chronic hepatitis C. Several case reports have suggested an association between interferon therapy and sarcoidosis with hypercalcemia. We report a case of severe hypercalcemic crisis with bilateral hilar lymphadenopathy in a male patient who...

Descripción completa

Detalles Bibliográficos
Autor principal: Albaker, Waleed I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410179/
https://www.ncbi.nlm.nih.gov/pubmed/22870420
http://dx.doi.org/10.4103/2230-8229.98308
_version_ 1782239693719470080
author Albaker, Waleed I.
author_facet Albaker, Waleed I.
author_sort Albaker, Waleed I.
collection PubMed
description Interferon is being increasingly used in the treatment of chronic hepatitis C. Several case reports have suggested an association between interferon therapy and sarcoidosis with hypercalcemia. We report a case of severe hypercalcemic crisis with bilateral hilar lymphadenopathy in a male patient who was receiving interferon therapy for hepatitis C. Gastroenterologists should be aware of this unusual but clinically important complication of interferon therapy.
format Online
Article
Text
id pubmed-3410179
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-34101792012-08-06 Hyercalcemia induced by interferon therapy in chronic hepatitis C Albaker, Waleed I. J Family Community Med Case Report Interferon is being increasingly used in the treatment of chronic hepatitis C. Several case reports have suggested an association between interferon therapy and sarcoidosis with hypercalcemia. We report a case of severe hypercalcemic crisis with bilateral hilar lymphadenopathy in a male patient who was receiving interferon therapy for hepatitis C. Gastroenterologists should be aware of this unusual but clinically important complication of interferon therapy. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3410179/ /pubmed/22870420 http://dx.doi.org/10.4103/2230-8229.98308 Text en Copyright: © Journal of Family and Community Medicine http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Albaker, Waleed I.
Hyercalcemia induced by interferon therapy in chronic hepatitis C
title Hyercalcemia induced by interferon therapy in chronic hepatitis C
title_full Hyercalcemia induced by interferon therapy in chronic hepatitis C
title_fullStr Hyercalcemia induced by interferon therapy in chronic hepatitis C
title_full_unstemmed Hyercalcemia induced by interferon therapy in chronic hepatitis C
title_short Hyercalcemia induced by interferon therapy in chronic hepatitis C
title_sort hyercalcemia induced by interferon therapy in chronic hepatitis c
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410179/
https://www.ncbi.nlm.nih.gov/pubmed/22870420
http://dx.doi.org/10.4103/2230-8229.98308
work_keys_str_mv AT albakerwaleedi hyercalcemiainducedbyinterferontherapyinchronichepatitisc

Ejemplares similares